Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name H19
   Synonyms H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2
   Region GRCh38_11:1995176-2001470    Sequence
   Ensembl ENSG00000130600
   RefSeq NR_002196
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name oral squamous cell carcinoma
   ICD-0-3 C06.9  M8070/3
   Methods qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc.
   Sample cell lines (SCC-4, SCC-15 , CAL-27, HSC-3,HSC-2), OSCC tissues
   Expression Pattern up-regulated
   Function Description

The correlation between H19 and microRNA miR-138 was detected.H19 was found to be upregulated in OSCC tissues and its high expression level was associated with the TNM stage and nodal invasion,and also correlated with a shorter overall survival of patients with OSCC.The knockdown of H19 significantly inhibited OSCC cell proliferation,migration,invasion and epithelial-mesenchymal transition (EMT),and induced apoptosis in vitro.it also suppressed subcutaneous tumor growth in vivo.H19 was found to regulate the expression of oncogene enhancer of zeste homolog 2 (EZH2) by competing with miR-138,the inhibition of miR-138 attenuated the inhibitory effects of H19 knockdown on OSCC cells.

   Pubmed ID 29344674
   Year 2018
   Title Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR-138 and releasing EZH2 in oral squamous cell carcinoma.
   External Links
   Links for  H19 GenBank       HGNC       lncrnadb       Noncode
   Links for  oral squamous cell carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.